Kings Group

Kings Global Biotech is an India-based integrated pharmaceutical company focused on developing, manufacturing, and marketing a broad portfolio of branded generics and related healthcare products. The company operates as a commercial-stage business rather than a clinical-stage biotech, with offerings spanning oncology, hematology-related products, nephrology, cardiology, gynecology, diabetology, beta-lactam cephalosporins, vitamins and minerals, and nutraceutical/herbal products. Its website describes seven manufacturing facilities in India and capabilities across multiple dosage forms including tablets, capsules, injectables, syrups, ointments, inhalers, aerosols, and pre-filled syringes. Kings Global Biotech appears to be active and privately held/unlisted, with headquarters in Pune, India and a branch office in Dubai. For a biotech analyst, this is best understood as a commercial generics-focused pharma manufacturer and marketer rather than a novel-drug R&D company.